Use of CR1-binding molecules in clearance and induction of immune responses

Details for Australian Patent Application No. 2005302312 (hide)

Owner Elusys Therapeutics, Inc.

Inventors Jones, Steven Marion; Pincus, Steven E.; Spitalny, George L.; Casey, Leslie S.; Mohamed, Nehal

Agent Shelston IP

Pub. Number AU-A-2005302312

PCT Pub. Number WO2006/050291

Priority 60/623,736 29.10.04 US; 60/664,472 22.03.05 US; 60/720,789 26.09.05 US; 60/720,956 26.09.05 US

Filing date 31 October 2005

Wipo publication date 11 May 2006

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/050291 Priority application(s): WO2006/050291

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302351-Heterocyclical anti-aromatic chromophore architectures

2005302301-Anti-Respiratory Syncytial Virus antibodies, antigens and uses thereof